Literature DB >> 2554855

Analysis of DNA synthesis in herpes simplex virus infected cells by dual parameter flow cytometry.

M Lehtinen1, P Kulomaa, O P Kallioniemi, J Paavonen, P Leinikki.   

Abstract

The DNA incorporation of a thymidine analogue bromodeoxyuridine (BrdUrd) in herpes simplex virus type 2 (HSV-2) infected cervical cancer cell lines (CaSki and C-33 A) was studied by dual parameter flow cytometry. HSV-2 infection resulted in an exponential increase in DNA synthesis in the CaSki cells. In the less permissive C-33 A cells the proportion of DNA-synthesizing cells cycled during HSV-2 infection. The inhibition of viral DNA synthesis by phosphonoformate (PFA) was able to inhibit the virus induced changes in the CaSki but not in the C-33 A cells. In the C-33 A cells a part of the virus induced cellular DNA synthesis represents repair replication of cellular DNA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554855     DOI: 10.1007/BF01317918

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

1.  Induction of host DNA synthesis and DNA polymerase by DNA-negative temperature-sensitive mutants of human cytomegalovirus.

Authors:  K Yamanishi; F Rapp
Journal:  Virology       Date:  1979-04-15       Impact factor: 3.616

2.  Stimulation of human cell DNA synthesis by defective herpes simplex virus type 2.

Authors:  M J Marcon; L S Kucera
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

Review 3.  Developmental aspects of selected antiviral chemotherapeutic agents.

Authors:  R J Whitley; C A Alford
Journal:  Annu Rev Microbiol       Date:  1978       Impact factor: 15.500

4.  Chromosome damage induced by herpes simplex virus type 1 in early infection.

Authors:  D S Peat; M A Stanley
Journal:  J Gen Virol       Date:  1986-10       Impact factor: 3.891

5.  Measurement of the kinetics of DNA repair synthesis after uv irradiation using immunochemical staining of incorporated 5-bromo-2'-deoxyuridine and flow cytometry.

Authors:  W Beisker; W N Hittelman
Journal:  Exp Cell Res       Date:  1988-01       Impact factor: 3.905

6.  DNA labeled during phosphonoacetate inhibition and following its reversal in herpesvirus infected cells.

Authors:  R J Jacob
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

7.  Flow cytometric evaluation of anti-herpes drugs.

Authors:  K S Rosenthal; C M Hodnichak; J L Summers
Journal:  Cytometry       Date:  1987-07

8.  Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus.

Authors:  J R Schlehofer; M Ehrbar; H zur Hausen
Journal:  Virology       Date:  1986-07-15       Impact factor: 3.616

9.  Polyclonal response of human lymphocytes to Chlamydia trachomatis.

Authors:  L Räsänen; M Lehtinen; M Lehto; J Paavonen; P Leinikki
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

10.  Nonstructural proteins of herpes simplex virus. II. Major virus-specific DNa-binding protein.

Authors:  K L Powell; E Littler; D J Purifoy
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

View more
  3 in total

Review 1.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1996-08

2.  The role of p53 in bleomycin-induced DNA damage in the lung. A comparative study with the small intestine.

Authors:  K Okudela; T Ito; H Mitsui; H Hayashi; N Udaka; M Kanisawa; H Kitamura
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

3.  Transgenic extracellular superoxide dismutase protects postnatal alveolar epithelial proliferation and development during hyperoxia.

Authors:  Richard L Auten; Michael A O'Reilly; Tim D Oury; Eva Nozik-Grayck; Mary H Whorton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-08-12       Impact factor: 5.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.